计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
T648840-5mg |
5mg |
期货 ![]() |
| |
T648840-10mg |
10mg |
期货 ![]() |
| |
T648840-25mg |
25mg |
期货 ![]() |
| |
T648840-50mg |
50mg |
期货 ![]() |
|
别名 | TLR7/8 激动剂 1 |
---|---|
规格或纯度 | ≥96% |
英文名称 | TLR7/8 agonist 1 |
生化机理 | TLR7/8 激动剂 1 是一种收费样受体(TLR7)/ TLR8 双拮抗咪唑喹啉。 |
储存温度 | 避光,-80℃储存 |
运输条件 | 超低温冰袋运输 |
产品介绍 |
TLR7/8 agonist 1 is a toll-like receptor ( TLR7 )/ TLR8 dual-agonistic imidazoquinoline. In Vitro TLR7/8 agonist 1 (Compound 5d) shows prominent immunostimulatory activities. TLR7/8 agonist 1 serves as a convenient precursor for the covalent attachment of fluorophores without significant loss of activity.TLR7/8 agonist 1 retains TLR7-agonistic activity with an EC 50 of 20 nM. TLR7/8 agonist 1 is covalently coupled directly to commercially-available fluorescein isothiocyanate and rhodamine B isothiocyanate. TLR7/8 agonist 1 (Compound 1) shows substantially different agonistic potencies in human TLR7 (50 nM) and TLR8 (55 nM) primary screens. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Assay Fresh human peripheral blood mononuclear cells ( hPBMC ) are isolated from human blood obtained by venipuncture with informed consent and as per institutional guidelines on Ficoll–Hypaque gradients. Aliquots of PBMCs (10 5 cells in 100 μL/well) are stimulated for 12 h with graded concentrations of test compounds (e.g., TLR7/8 agonist 1; 0.1, 1, 10, and 100 μg/mL ). Supernatants are isolated by centrifugation and are assayed in duplicates using analyte-specific multiplexed cytokine/chemokine bead array assays. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:TLR7 TLR8 |
活性类型 | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
分子类型 | 小分子 |
---|---|
IUPAC Name | 1-[[4-(aminomethyl)phenyl]methyl]-2-butylimidazo[4,5-c]quinolin-4-amine |
INCHI | InChI=1S/C22H25N5/c1-2-3-8-19-26-20-21(17-6-4-5-7-18(17)25-22(20)24)27(19)14-16-11-9-15(13-23)10-12-16/h4-7,9-12H,2-3,8,13-14,23H2,1H3,(H2,24,25) |
InChi Key | SDSKFWHQCNBICO-UHFFFAOYSA-N |
Canonical SMILES | CCCCC1=NC2=C(N1CC3=CC=C(C=C3)CN)C4=CC=CC=C4N=C2N |
Isomeric SMILES | CCCCC1=NC2=C(N1CC3=CC=C(C=C3)CN)C4=CC=CC=C4N=C2N |
PubChem CID | 52945312 |
分子量 | 359.5 |
分子量 | 359.500 g/mol |
---|---|
XLogP3 | 3.500 |
氢键供体数Hydrogen Bond Donor Count | 2 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 6 |
精确质量Exact Mass | 359.211 Da |
单同位素质量Monoisotopic Mass | 359.211 Da |
拓扑极表面积Topological Polar Surface Area | 82.800 Ų |
重原子数Heavy Atom Count | 27 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 464.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |